- Carrasquilla-Sotomayor, M., Alvis-Zakzuk, N. J., de la Rosa, F. G., Zakzuk, J. A., Figueroa, R. M., Machado, P. M., … & Diazgranado, S. H. (2017). Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer. Value in Health, 20(9), A876. http://www.valueinhealthjournal.com/article/S1098-3015(17)32919-4/abstract
- Martin Romero, Nelson Alvis Guzmán, Diana Chavez Bejarano, Elizabeth Karpf Benavides. Análisis de costo-efectividad del uso de Detemir en pacientes con diabetes tipo 2 en riesgo de presentar eventos cardiovasculares y muerte en Colombia / Cost-effectiveness of using Detemir for patients with type 2 diabetes in risk of cardiovascular events. Salud Uninorte. Vol 30, No 2 (2014). http://rcientificas.uninorte.edu.co/index.php/salud/article/view/4720
- Romero M, Chávez D, De los Ríos M, Alvis-Guzmán N. Cost effectiveness of nilotinib, dasatinib and imatinib as first-line treatment for chronic myeloid leukemia in Colombia, 2012. Biomédica. 2014; 34(1). http://www.revistabiomedica.org/index.php/biomedica/article/view/1446/1899
- Fernando De la Hoz-Restrepo, Carlos Castañeda-Orjuela, Angel Paternina, Nelson Alvis-Guzman. Systematic Review of Incremental Non-Vaccine Cost Estimates Used in Cost-Effectiveness Analysis on the Introduction of Rotavirus and Pneumococcal Vaccines. Vaccine, Volume 31, Supplement 3, 2 July 2013, Pages C80-C87. http://www.sciencedirect.com/science/article/pii/S0264410X1300666X
- Castañeda-Orjuela, N. Alvis, W. Coronel, F. De la Hoz-Restrepo. PIN58 – Cost-Effectiveness Analysis Of Introduction Of Meningococcal Conjugate Vaccine In Colombia, 2011. Value in Health, Volume 16, Issue 3, May 2013, Pages A89-A90. Disponible en http://www.ispor.org/publications/value/JVAL_16-3_FINAL.pdf
- Romero, R. Marrugo, O. Sanchez, S. Lopez, Alvis. PDB44 – Cost-Effectiveness Analysis Of Using Hypoglycemic Agents (Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin, Glimepiride And Glibenclamide) With Metformin In Diabetes In Colombia. Value in Health, Volume 16, Issue 3, May 2013, Page A163. Disponible en http://www.ispor.org/publications/value/JVAL_16-3_FINAL.pdf
- Martín Romero-Prada, Nelson Alvis-Guzmán, Elizabeth Karpf-Benavides. Análisis de costo-efectividad del uso de calcio más ácido linoleico para la prevención de la hipertensión inducida por el embarazo en mujeres con riesgo en Colombia. Revista Colombiana de Obstetricia y Ginecología Vol. 63 No. 3 • 2012. http://www.fecolsog.org/revista/revista.php
- Paternina-Caicedo, Angel, De la Hoz-Restrepo, Fernando, Gamboa-Garay, Oscar., Castañeda-Orjuela, Carlos, Velandia-González, Martha, Alvis-Guzmán, Nelson. “How cost effective is universal varicella universal vaccination in developing countries? A case- study from Colombia”, Vaccine, Volume 31, Issue 2, 2 January 2013, Pages 402-409. http://www.ncbi.nlm.nih.gov/pubmed/23174195
- Iris Contreras-Hernández, Flavio Eduardo Prisco, Nelson Alvis-Gúzman, Stephen Doral Stefani. El uso de evaluación económica para la toma de decisiones en intervenciones oncológicas: la experiencia de México, Colombia y Brasil. PharmacoEconomics – Spanish Research Articles 9 (4): 117-132, 2012 http://www.pharmacoeconomics-sra.com/index.php
- Martin Emilio Romero, Nelson Alvis, Magali de Acevedo, and Diana Rocío Chávez. Cost Effectiveness of front Nilotinib or Dasatinib VS imatinib as first line treatment of Chronic Myeloid Leukemia In Colombia. Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 4193. http://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/4193?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=alvis&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
- Chocontá-Piraquive LA, Alvis Guzmán N, De la Hoz Restrepo F. Costo-efectividad de la vacunación contra influenza pandémica en mujeres embarazadas en Colombia. Rev Panam Salud Publica. 2012;31(6):447–53. http://www.scielosp.org/pdf/rpsp/v31n6/v31n6a01.pdf
- Romero Martin, N. Alvis Nelson, A.C. Alfonso Camilo, K.E. Karpf Elizabeth, U.A. Upegui Angie. Cost Minimization Analysis of the Dienogest Use in Patients with Endometris in Colombia and Argentina. PIH20. Value in Health, Volume 15, Issue 4, June 2012, Page A195. http://www.ispor.org/valueinhealth_index.asp
- Romero Martin, N. Alvis Nelson, D.L.R.M. De los Ríos Magalí, C.D. Chávez Diana. Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011. PCN60 Value in Health, Volume 15, Issue 4, June 2012, Page A218. http://www.ispor.org/valueinhealth_index.asp
- De la Hoz-Restrepo, C.A. Castañeda-Orjuela, Alvis, A. Paternina. Review of Administration’s Cost Assumption of Rotavirus and Pneumococcal Vaccines Cost-Effectiveness Analyses. PRM18. Value in Health, Volume 15, Issue 4, June 2012, Page A162. http://www.ispor.org/valueinhealth_index.asp
- Martin Romero Prada, Edgar Villa Pérez, Nelson Alvis, Elizabeth Karpf Benavides and María Alejandra Sánchez Gómez. Impact evaluation of the Betaplus ® support program for patients with multiple sclerosis, in Colombia. Gac Sanit. 2012; 26(Espec Congr 2):209
- Castaneda-Orjuela C, Alvis-Guzman N, Paternina AJ, De la Hoz-Restrepo F. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population. Vaccine. 2011 Oct 13;29(44):7644-50. http://www.ncbi.nlm.nih.gov/pubmed/21854825
- Romero, C. Arango, F. Espinel, E. Karpf, M. Sanabria, Alvis. Análisis de costo-efectividad del uso de Levonorgestrel-Uis frente a otros tratamientos en menorragia idiopática. Value in Health 14 (2011) A535-A570 http://download.journals.elsevierhealth.com/pdfs/journals/1098-3015/PIIS1098301511032141.pdf
- De la Hoz, N. Alvis, J. Moreno, Alvis, A. Paternina. PIN27 Cost-effectiveness analysis of the introduction of acellular pertussis in colombian adolescents . Value in Health, Volume 14, Issue 3, May 2011, Page A118 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996760749&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=b13d4b0e3eb9b48181f1e5e7bd85969b&searchtype=a
- Alvis, M. Romero, A. Paternina, F. De la Hoz. PIN22 Cost-effectiveness of a catch-up dose of hepatitis b vaccine in colombian adolescents. Value in Health, Volume 14, Issue 3, May 2011, Page A117 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- F De la Hoz, N. Alvis, O. Gamboa, C. Castañeda, A. Paternina. PIN25 Cost-effectiveness analysis of the introduction of the varicella vaccine in Colombia Value in Health, Volume 14, Issue 3, May 2011, Page A118. http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- Alvis N, De la Hoz F, Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia. Colomb Med. 2010; 41: 315-22 http://redalyc.uaemex.mx/pdf/283/28315594004.pdf
- N Alvis, F De La Hoz, J Narvaez. PIN28 Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Colombia . Value in Health, Volume 13, Issue 3, May 2010, Page A191 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- N Alvis, F De La Hoz, C Castañeda, A Paternina. PIN23 Cost-effectiveness of pneumococcal vaccine polyvalent (PPSV23) in adults older than 60 years old in Colombia. Value in Health, Volume 13, Issue 3, May 2010, Page A190 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- J Narváez, N Alvis, F de La Hoz, J Orozco, A Porras. PRS16 An economic evaluation of a pharmacological intervention using varenicline as therapy for smoking cessation Value in Health, Volume 12, Issue 3, May 2009, Page http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- JI Godoy, AF Cardona, N Alvis, CH Arango, M Romero, A Spath, P Ramirez, HA Caceres, MF Quijano. PIN26 Economic evaluation of sunitinibvs. interferon-alfa (IFN-alfa) in first-line treatment of metastatic renal cell carcinoma (MRCC) in Colombia Value in Health, Volume 11, Issue 3, May-June 2008, Page A100
- De La Hoz, N Alvis, J Echeverry, J Narváez PIN16 Evaluación económica del impacto de la introducción de la vacuna de neumococo en Bogotá, D.C Value in Health, Volume 12, Issue 7, October 2009, Page A518 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- M Romero, CH Arango, N Alvis, O Canon. CS10 Análisis de costo efectividad y costo utilidad del Interferón Beta-1b (INFB1b) frente a Interferón Beta-1a (INFB1a) para el tratamiento de esclerosis múltiple remitente recidivante en Colombia Value in Health, Volume 12, Issue 7, October 2009, Page A487 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- F de La Hoz, N Alvis, J Narváez, O Gamboa, A Chocontá PCN35 Cost-effectiveness of Human Papillomavirus vaccine in Colombia IN 2007 Value in Health, Volume 12, Issue 3, May 2009, Page A42 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- Alvis N, De la Hoz F, Narvaez J, Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Colombia. Value in Health. 2010. 13 (3) S191 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- Alvis N, De la Hoz F, Narvaez J, Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en Colombia. Rev Pan Sal Pub. 2010. 27(5) 352 – 359 http://www.scielosp.org/pdf/rpsp/v27n5/a05v27n5.pdf
- Alvis N, De la Hoz F, Castañeda C, Paternina A. Cost-effectiveness of Pneumococcal Vaccine Polyvalent (PPSV23) in adults older than 60 years old in Colombia. Value in Health 2010, 13 (3) A191 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1996763228&_sort=r&_st=13&view=c&_acct=C000025027&_version=1&_urlVersion=0&_userid=506061&md5=20341a6158e4525d18b06c0f19a76112&searchtype=a
- Porras-Ramírez A, Alvis N, Rico A, Alvis L, Castañeda C, Velandia M, De la Hoz F, Costo Efectividad de la Vacunación contra Influenza en Menores de 2 Años y Mayores de 65 Años en Colombia. Revista de Salud Pública. 2009. 11(6) 689-99 http://www.scielo.unal.edu.co/scielo.php?script=sci_arttext&pid=S0124-00642009000500002&lng=es&nrm=
- Alvis N, De la Hoz F, Gómez RD. Medicamentos antivirales para la epidemia de influenza: efectividad y costo- efectividad del oseltamivir. Infectio. 2009 13 (3) 223 – 230 http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_articulo=59126&id_seccion=2447&id_ejemplar=5980&id_revista=93
- Dagna Constenla, Sue Goldie, Nelson Alvis, Meredith O’Shea, Steven Sweet, Marite Valenzuela, Gabriel Cavada, Fernando de la Hoz, Emilia Koumans, Maria N Labbo, Cait Koss, Hector Posso. Health and Economic Outcomes of Human Papillomavirus (HPV) Vaccination in Selected Countries in Latin America. Sabin Vaccine Institute. Washington D.C. 2009. Disponible en http://www.sabin.org/files/Vol%20II_Final%20HPV%20Report%2017Feb10.pdf
- Otero A, Alvis N, Palomino R, “Análisis costo efectividad de la técnica anestésica subaracnoidea comparada con técnica anestésica en colecistectomía abierta”. Col. Anest. 36 (3) 179 – 185 http://redalyc.uaemex.mx/redalyc/pdf/1951/195114549005.pdf
- Alvis N, Alvis L, Orozco J, Costos efectividad del Gas Natural domiciliario como tecnología Sanitaria. Rev Salud Publica 2008. 10 (4) 537-549 http://www.scielosp.org/pdf/rsap/v10n4/v10n4a04.pdf
- Godoy JI, Cardona AF, Alvis N, Arango CH, Romero M, Spath A, Ramirez P, Caceres HA, Quijano MF. Economic Evaluation of Sunitinib as Opposed to Interpheron-Alpha for the First-Line Treatment of Renal Metastastic Cell Carcinoma in Colombia. Rev Colomb Cancerol 2008;12(2):63-73 http://www.cancer.gov.co/documentos/RevistaCC2008%20Vol%2012(2)/rcc2008v12n2a02.pdf
- Godoy JI, Cardona AF, Alvis N, Arango CH, Romero M, Spath A, Ramirez P, Caceres HA, Quijano MF. Economic evaluation of Sunitinib vs. Interferon-Alfa (ifn-alfa ) in first-line treatment of metastatic renal cell carcinoma (Mrcc) in Colombia. 2008, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 1098-3015/08/A29 A29–A311. Value in Health vol 2 Nº 3 pp A100.
- Goldie SJ, Diaz Sanchis M, Constenla D, Alvis N, Andrus J, Kim SY. Regional Report on HPV Vaccines and Screening – Latin America . Chapter 13: Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008; 26 (S11): p: L59-L72 http://www.sciencedirect.com/science/article/pii/S0264410X08006737
- Alvis Guzmán N, De La Hoz Restrepo F, Vivas Consuelo D. Relación costo-efectividad de la vacuna contra Haemophilus influenzae tipo b en niños menores de dos años de edad en Colombia [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia]. Rev Panam Salud Publica. 2006;20(4):248-255″ http://www.scielosp.org/scielo.php?pid=S1020-49892006000900005&script=sci_arttext